









Mercado
/
Acciones
/
nasdaq-livn
/

LivaNova PLC

LIVN

56.830USD

+2.890+5.36%

Cierre 11/04, 16:00（ET）Cotizaciones retrasadas 15 min

3.10BCap. mercado

PérdidaP/E TTM



LivaNova PLC

56.830

+2.890+5.36%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de LivaNova PLC Compañía

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

Información de LivaNova PLC



Símbolo de cotizaciónLIVN

Nombre de la empresaLivaNova PLC

Fecha de salida a bolsaOct 19, 2015

Director ejecutivoMr. Vladimir A. Makatsaria

Número de empleados2900

Tipo de seguridadOrdinary Share

Fin del año fiscalOct 19

Dirección20 Eastbourne Terrace

CiudadLONDON

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited Kingdom

Código postalW2 6LG

Teléfono442033250662

Sitio Webhttps://www.livanova.com/

Símbolo de cotizaciónLIVN

Fecha de salida a bolsaOct 19, 2015

Director ejecutivoMr. Vladimir A. Makatsaria

Ejecutivos de LivaNova PLC



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Mr. Francesco Bianchi

Independent Director

9.03K

-14.25%

Franco Poletti ,

President, Cardiopulmonary Business Unit

8.52K

+4.49%

Ms. Brooke Story

Independent Director

6.48K

+86.48%

Mr. Michael Damon Hutchinson

Senior Vice President, Chief Legal Officer, Company Secretary

5.67K

Ahmet Tezel

Senior Vice President, Chief Innovation Officer

1.94K

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Mr. Francesco Bianchi

Independent Director

9.03K

-14.25%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Sin datos

Por regiónUSD

Nombre

Ganancia

Proporción

United States

188.47M

53.46%

Rest of World

97.27M

27.59%

Europe

66.78M

18.94%

Por negocio

Por región

Sin datos

Estadísticas de accionistas

Actualizado: mar., 19 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.67%

PRIMECAP Management Company

8.50%

The Vanguard Group, Inc.

4.47%

Millennium Management LLC

4.44%

State Street Investment Management (US)

3.81%

Otro

67.10%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.67%

PRIMECAP Management Company

8.50%

The Vanguard Group, Inc.

4.47%

Millennium Management LLC

4.44%

State Street Investment Management (US)

3.81%

Otro

67.10%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

47.30%

Investment Advisor/Hedge Fund

34.79%

Hedge Fund

15.49%

Research Firm

2.72%

Pension Fund

2.17%

Bank and Trust

1.36%

Individual Investor

0.36%

Sovereign Wealth Fund

0.09%

Insurance Company

0.04%

Participación institucional



Actualizado: dom., 5 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

561

56.75M

103.93%

-8.11M

2025Q2

564

56.85M

104.11%

-6.95M

2025Q1

581

56.61M

103.82%

-8.04M

2024Q4

586

56.98M

104.84%

-8.56M

2024Q3

563

55.15M

101.56%

-9.48M

2024Q2

546

57.21M

105.64%

-8.52M

2024Q1

547

58.00M

107.51%

-6.90M

2023Q4

532

56.62M

105.11%

-7.28M

2023Q3

527

56.14M

104.20%

-8.51M

2023Q2

529

55.56M

103.33%

-9.55M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

6.37M

11.67%

-150.58K

-2.31%

Jun 30, 2025

PRIMECAP Management Company

4.64M

8.5%

+32.94K

+0.71%

Jun 30, 2025

The Vanguard Group, Inc.

2.44M

4.47%

-214.69K

-8.09%

Jun 30, 2025

Millennium Management LLC

2.43M

4.44%

+360.76K

+17.47%

Jun 30, 2025

State Street Investment Management (US)

2.08M

3.81%

-17.41K

-0.83%

Jun 30, 2025

AQR Capital Management, LLC

2.05M

3.75%

+478.52K

+30.45%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.61M

2.96%

+282.33K

+21.20%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.43M

2.62%

+18.55K

+1.31%

Jun 30, 2025

Wellington Management Company, LLP

1.28M

2.34%

+805.32K

+170.32%

Jun 30, 2025

Artisan Partners Limited Partnership

1.25M

2.29%

+661.48K

+112.86%

Jun 30, 2025

ETFs relacionados



Actualizado: dom., 2 de nov

Nombre

Proporción

SPDR S&P Health Care Equipment ETF

1.52%

JPMorgan Active Small Cap Value ETF

1.19%

Federated Hermes MDT Small Cap Core ETF

0.56%

Invesco NASDAQ Future Gen 200 ETF

0.45%

Global X Aging Population ETF

0.41%

Simplify Health Care ETF

0.4%

iShares US Small Cap Value Factor ETF

0.36%

Avantis US Small Cap Equity ETF

0.33%

iShares U.S. Medical Devices ETF

0.33%

First Trust Active Factor Mid Cap ETF

0.32%

SPDR S&P Health Care Equipment ETF

Proporción1.52%

JPMorgan Active Small Cap Value ETF

Proporción1.19%

Federated Hermes MDT Small Cap Core ETF

Proporción0.56%

Invesco NASDAQ Future Gen 200 ETF

Proporción0.45%

Global X Aging Population ETF

Proporción0.41%

Simplify Health Care ETF

Proporción0.4%

iShares US Small Cap Value Factor ETF

Proporción0.36%

Avantis US Small Cap Equity ETF

Proporción0.33%

iShares U.S. Medical Devices ETF

Proporción0.33%

First Trust Active Factor Mid Cap ETF

Proporción0.32%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

